Fernanda Proença

University of Minho, Portugal

Fernanda Proença completed the Licenciatura degree at the University of Coimbra (1976) and the PhD at the University of Manchester (UK, 1981). She is currently a Full Professor at the University of Minho, where she started her career in 1977 as an Assistant Professor.
Her research interests include the synthesis of nitrogen- and oxygen-containing heterocyclic compounds, mainly imidazole, purine and chromene derivatives with potential biological activity. The prepared compounds are submitted to in silico, in vitro and in vivo screening through collaboration with national and international partners mainly as antipsychotics or as anticancer agents. During the past decade, the skills in synthetic organic chemistry have also been applied to the chemical functionalization of carbon nanotubes, nanofibers and graphene for various applications including electrochemical sensors and the preparation of composites in collaboration with the Institute for Polymers and Composites of the University of Minho. She coordinates an Interreg project on the "Recovery of organic waste: production of humic substances" involving partners of the University of Minho and Santiago de Compostela and Companies from the north of Portugal and Galicia.
She is the co-author of more than 120 scientific publications and supervised several MSc and PhD students and postdoctoral researchers. She has been a member of national and international project and scholarship evaluation committees. She was also involved in academic management tasks, as director of the Department of Chemistry, director of the Chemistry Research Centre and vice-president of the School of Sciences for research.

Prof. Dr. Herman S. Overkleef

Leiden University, The Netherlands

Prof. Dr. Herman S. Overkleeft (12-04-1969) studied chemistry at the University of Amsterdam and received his PhD degree in 1997 on his Thesis ‘Azasugars. Synthesis and evaluation as glycosidase inhibitors’ (promotor Professor Dr. Upendra Pandit). He performed postdoctoral research with Professor Dr. Jacques van Boom (Leiden University, 1997-1999) and Professor Dr. Hidde Ploegh (Harvard Medical School, 1999-2001). Since 2001 he is Professor and head of the Bioorganic Synthesis (BIOSYN) group at the Leiden Institute of Chemistry, Leiden University. The research of the BIOSYN group focuses on the design and synthesis of peptides, nucleic acids and carbohydrates, their hybrid structures and their structural analogues. These compounds are applied in-house and through numerous collaborations in biological and biomedical research. Specific focus is on the development of activity-based probes for chemical biology research, predominantly on proteasomes and glycosidases. His work on modulators of glycosphingolipid metabolism has yielded a largest and comprehensive glycomimetics library and resulted in the creation of the biotech start-up company, Azafaros, whose aim is to develop new therapeutics for neuropathic Gaucher disease (www.azafaros.com). Overkleeft is recipient of a VICI (2003) and ERC AdG (2011) grant. He was awarded the KNCV Gold Medal (2008), a Wilhelm Friedrich Bessel Forschungspreis (2012), and the Jeremy Knowles Award (2015). In 2018 he was elected member of the Royal Dutch Academy of Arts and Sciences (KNAW). He is author of 550 research papers, reviews, book chapters and patents

Tomas Torres

Universidad Autónoma de Madrid, Spain

Tomás Torres is Head of the Institute for Advanced Research in Chemical Sciences (IAdChem) and Full Professor of Organic Chemistry at the Autónoma University of Madrid (UAM) and Associated Senior Scientist at the IMDEA Nanoscience. In addition to various aspects of synthetic and supramolecular chemistry, his current research interests include the preparation and study of optical properties of organic functional materials. His group, that presently consists of twenty five researchers, is currently exploring several areas of basic research and applications of phthalocyanines, porphyrins and carbon nanostructures (fullerenes, carbon nanotubes, graphene), including organic and hybrid solar cells, and photodynamic therapy, with a focus on nanotechnology.

Véronique Gouverneur

University of Oxford, UK

Véronique Gouverneur secured a PhD in chemistry at the Université Catholique de Louvain (LLN, Belgium), under the supervision of Professor L. Ghosez. In 1992, she moved to a postdoctoral position with Professor R. Lerner at the Scripps Research Institute (California, USA). She accepted a position of Maître de Conférence at the University Louis Pasteur in Strasbourg (France). She worked with Dr C. Mioskowski and was Associate Member of the ISIS Institute directed by Professor J-M. Lehn during this period. Veronique started her independent research career at the University of Oxford in 1998 in the Chemistry Faculty and was promoted to Professor of Chemistry in 2008. Her research aims at developing new approaches to address long-standing problems in the synthesis of fluorinated molecules including pharmaceutical drugs and probes for imaging (Positron Emission Tomography). To date, she has mentored more than 30 Postdocs and supervised 40 PhD (= DPhil in Oxford) to completion. Since her appointment in Oxford, she holds a tutorial fellowship at Merton College Oxford where she teaches organic chemistry. She has coordinated European ITN projects (currently H2020-MSCA-ITN-2016, FLUDD), and is the (co)author of more 180 peer-reviewed publications and 10 patents. Her research has been rewarded by numerous prizes and distinctions- 2015 ACS Award for Creative work in Fluorine Chemistry, RSC Tilden Prize 2016, Tetrahedron Chair 2016 and more recently the RSC Organic Stereochemistry Award and Elected Fellow of the Royal Society.

Amélia Rauter

University of Lisbon, Portugal

Amélia Pilar Rauter is Full Professor of Organic Chemistry, the President of the Department of Chemistry and Biochemistry, at Faculdade de Ciências, Universidade de Lisboa, and the Coordinator of its Center of Chemistry and Biochemistry (CQB). She is the President of the International Carbohydrate Organisation and the Secretary of the European Carbohydrate Organisation, and serves IUPAC as Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, and as Titular Member of IUPAC Division of Chemical Nomenclature and Structure Representation and as Associate member of its Interdivisional Committee on Terminology, Nomenclature and Symbols. She is the founder of the Portuguese Society of Chemistry Carbohydrate Group, and the founder and leader of the CQB Carbohydrate Chemistry Group at Faculdade de Ciências, Universidade de Lisboa (FCUL). Her research covers the development of new molecular entities for the treatment/prevention of metabolic (diabetes), degenerative diseases (Alzheimer´s and Prion diseases, cancer), and infection, either isolated from natural resources or accessed through rational design and synthesis. She has coordinated/participated as principal investigator of FCUL in projects sponsored by EU, IUPAC, NATO, FCT, QREN, FLAD, CRUP, among other funding agencies and programs, with national and international companies. She is Editor of the Royal Society of Chemistry Carbohydrate Chemistry book series, Associated Editor of the Mediterranean Journal of Chemistry, and member of journals advisory board in medicinal/Organic/Carbohydrate Chemistry, namely European Journal of Organic Chemistry (Wiley), Medicinal Chemistry (Bentham Science), Journal of Carbohydrate Chemistry (Taylor & Francis), among others. She has published more than 150 papers and book chapters, authored 8 granted patents and has been invited as speaker of national and international meetings (Gordon Conference, ECO and ICS meetings, and many others). Among her honors, she was awarded with the Mention of Excellency

Diana Pinto

University of Aveiro, Portugal

Diana C. G. A. Pinto studied chemistry at the University of Aveiro (Portugal) where she graduated in analytical chemistry in 1991. In 1996 she received her PhD in chemistry at Aveiro University. She then joined the Department of Chemistry at Aveiro University where she is currently Assistant Professor of Organic Chemistry. Diana C. G. A. Pinto is an expert in organic synthesis, includes the development of new strategies towards the synthesis of nitrogen and oxygen heterocyclic compounds that can be used as new drugs. Over the years, her research has also been focused on the application of environmental friendly methodologies in organic synthesis, with prominence on the application of microwave irradiation. Nowadays, Diana C. G. A. Pinto main research interests are centered in the organic synthesis field and natural products chemistry. Specifically: a) establishment of new synthetic organocatalyzed, metal-catalyzed and enzymatically catalyzed methods; b) synthesis of polyphenolic and nitrogen heterocyclic compounds with potential biological activities; c) establishment of chemical profiles of natural resources (terrestrial and marine) using GC- and UHPLC-MS; and b) extraction, purification and structural elucidation of natural compounds from natural resources (terrestrial and marine).

Carlos A. M. Afonso

Faculty of Pharmacy, University of Lisbon

Carlos A. M. Afonso is currently Full Professor at Faculty of Pharmacy, University of Lisbon. He received his PhD in 1990 under supervision of Professor C. D. Maycock, subsequently became Assistant Professor at New University of Lisbon and Associate Professor at Instituto Superior Técnico in Lisbon (2004-2010), and took a postdoctoral fellow (1990) at Imperial College of Science Technology and Medicine (W.B. Motherwell) and sabbatical leave (1997/1998) at University of Bath,UK (Jonathan Williams) and at the University of Toronto (Robert Batey). His current research is mainly focused on catalysed synthetic methodologies, green chemistry, valorisation of natural resources, biotransformations and synthesis of bioactive molecules.

Teresa M. V. D. Pinho e Melo

University of Coimbra

Teresa Pinho e Melo studied Chemistry at the University of Coimbra, where she graduated in 1985, got her M.Sc. in 1991 and her Ph.D. in Organic Chemistry in 1995. She was Research Fellow at the University of Liverpool (1992-1993). She received her Habilitation in Organic Chemistry in 2003, University of Coimbra. She is currently Associate Professor and Head of the Organic Chemistry Research Group at the University of Coimbra, Portugal. Her research interests are in the area of Synthetic and Mechanistic Heterocyclic Chemistry and Medicinal Chemistry. She has published more than 140 peer-reviewed papers in international journals and 11 patents/patent applications.

Alexandra Paulo

University of Lisbon

Alexandra Paulo graduated in Pharmaceutical Sciences by University of Lisbon and got her PhD in Pharmacy by King´s College London in 1998. Since then, she has a position of Assistant Professor at Faculty of Pharmacy of University of Lisbon and in 2014 obtained the Professor Habilitation Title in Medicinal Chemistry by this University. A. Paulo is member of iMed.ULisboa and her research has been focus in the discovery of novel small molecules to translate into innovative therapies for oncology and parasitology (ORCID ID 0000-0003-1433-5402). Her most recent project aims to develop selective anticancer drugs by targeting the expression of oncogenes and tumor suppressor p53.

Samuel Silvestre

University of Beira Interior, Covilhã

Samuel Silvestre holds a Degree in Pharmaceutical Sciences (since June 2002) and a PhD in Pharmacy, with specialization in Pharmaceutical Chemistry (since May 2007) After a Community Pharmacy experience, he was a Post-Doctoral Fellow at the Health Sciences Research Centre (CICS), Faculty of Health Sciences, University of Beira Interior, Covilhã. Since March 2008 he is an integrated researcher member at CICS, and since July 2009 he is also Assistant Professor at the same Faculty. Over the years, his main scientific interests have been Medicinal Chemistry, Green Chemistry and Pharmaco-toxicology and has been mainly working on the design, chemical synthesis and biological evaluation of steroidal and heterocyclic compounds.
http://www.ubi.pt/Pessoa/sms
http://www.cics.ubi.pt/Investigador/1126
https://orcid.org/0000-0003-4297-5108

João Conde

IMM, University of Lisbon

João Conde received his PhD in Biology, specialty in NanoBiotechnology from the NOVA University and Universidad de Zaragoza in 2014, under the FP7 European Consortium NanoScieE+ – NANOTRUCK for the development of multifunctional gold nanoparticles for gene silencing. After, he was a Marie Curie Fellow at the Massachusetts Institute of Technology, Harvard-MIT Division for Health Sciences and Technology and in School of Engineering and Materials Science, Queen Mary University of London. He joined IMM in 2017 as a Junior Investigator. In 2019, he won an ERC Starting Grant to build a genetic biobarcode to profile breast cancer heterogeneity.
His scientific interests are focused in the application of multifunctional nano-and-biomaterials for cancer therapy and diagnosis, especially for tumour imaging and targeting, gene therapy and drug delivery.
The main aspects related to the recognition and diffusion of his early contributions are: 60 articles in journals in fields of Cancer therapy, Materials Science and Biomedicine, more than 30 articles are as 1st author and more than 20 articles as corresponding author and cited more than 3500 times (h-index 32). Four of them have been selected as cover page of journals such as Adv. Functional Materials, Adv. Healthcare Materials, Analytical and Bioanalytical Chemistry and BioTechniques. Moreover, 6 international patents were submitted and approved, all with relevant developments in nanomaterials-based platforms for cancer therapy and diagnosis. He was also awarded with several international awards, including the Wellcome Image Awards 2017, the Nano-Micro Letters Researcher Award, and the National Cancer Institute Image award.

Fernanda Borges

University of Porto

Fernanda Borges is Associate Professor with habilitation of the Department of Chemistry and Biochemistry of Faculty of Sciences of University of Porto and the Coordinator of the Medicinal Chemistry Group in Chemistry Research Centre of the University of Porto (CIQUP). She received her MSc and PhD (Pharmaceutical Chemistry) in Pharmacy from the Faculty of Pharmacy, University of Porto, Portugal. Her current research is focused in the design and development of new chemical entities to be used in the prevention/therapy of neurodegenerative, liver or infectious diseases. The application of nanotechnology for therapy and diagnostics is up-to-date a complementary research. She authored more than 320 publications in peer review journals (Scopus h-index: 49), 10 international book chapters, and 3 patents. She is one of the founders of MitoTAG spin-off.

Step to register and participate

• Please be aware of the steps to undertake to register and participate. The guidelines will improve the efficiency on all organization levels. Thank you for your collaboration!
• The management platform is prepared for online invoice emission. The correct accounting data should be fulfilled in the registration platform (name of the legal organization receiving the invoice and the corresponding address and tax number) in order to avoid possible errors during the invoice emission process.
• Abstract submission is only possible after your online registration.
• After registering, you will receive a link to activate your account. Then you'll be able to login at your Personal Area without restrictions. In this area, and using the password, you can submit your abstract(s) and replace the submitted abstract(s) at anytime until the deadline for abstract submission.
• If you don’t receive an e-mail with the confirmation of the abstract(s) submission, please contact us.
• Please comply with the payment deadline; any form of payment can be used. It is recommended to avoid payments on location since they could imply some delay in issuing the receipts.
• After identifying the payment, an online invoice will be emitted. The online invoice are legal documents and can be printed and used in our institution accounting system.
• After payment, if you don’t receive a confirmation e-mail in a period of 7 days, please contact us and/or send us the payment confirmation document (if you are not the first bearer of the bank account, or if the payment is going to be carried out by an institution, please let us know).

Payments

All fees for the Congress registration should be paid in EUR (€). VAT is included in all fees. In case payment is made via bank transfer, please note that we must receive the full amount clear of all bank charges.

Cancellation/Refund Policy

All cancellations must be notified in writing (by mail, fax or e-mail) to the Meeting secretariat according to the following conditions. Please note cancellations received:

• For any cancellation received until 15 December, less an administrative fee equal to 10 percent of your registration fee (in EUR)
• For any cancellation received after 16 December, no refund will be made
• All bank charges involved in the transactions are paid by the participant
• Any request for refund must be addressed to 13ENQO6ENQT@chemistry.pt
• Refunds will be handled after the Conference

Rules

• Before abstract submission the author should proceed with the Online Registration.
• After registering, you will receive an e-mail with the Code to access the abstract submission tool in your Personal Area.
• In the Personal Area you will be able to submit your abstract(s) and replace the submitted abstract(s) at anytime until the deadline for abstract submission.
• For each abstract you should indicate the other authors and the preferred type of presentation (Oral or Poster).
• If you don’t receive an e-mail with the confirmation of the abstract(s) submission, please contact us.

Abstract Guidelines

• The first author must be registered.
• The abstract will only be considered if the standards are met. The first author or corresponding author must be registered. 
• Abstract text in A4 format page, since the abstract can only occupy a single page A4. Please see here a template format.
• The abstract must be submitted electronically. Abstracts submitted by fax or email will not be considered
• The abstract should be in MSWord format or in another compatible format.
• Abstracts of authors who are not registered will NOT be accepted.